<DOC>
	<DOCNO>NCT01006135</DOCNO>
	<brief_summary>The objective observational study collect evaluate data Health Related Quality Life ( HRQoL ) Spiriva deliver HandiHaler , use disease specific SGRQ national sample Central &amp; Central European patient vary severity chronic obstructive pulmonary disease ( COPD ) real life set 6 month .</brief_summary>
	<brief_title>Spiriva Observational Study Measuring Saint George 's Respiratory Questionnaire ( SGRQ ) Routine Medical Practice Central &amp; Eastern European Region</brief_title>
	<detailed_description>Study Design : open-label , uncontrolled single arm post-marketing surveillance study</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>Inclusion criterion : 40 year old male female ambulatory outpatient . Clinical diagnosis Chronic Obstructive Lung Disease ( COPD ) ( Global Initiative Chronic Obstructive Lung Disease ( GOLD ) Guidelines : Forced expiratory Volume one second ( FEV1 ) / Forced Vital Capacity ( FVC ) &lt; 0.7 FEV1 &lt; 80 % predict ) . Stable patient , without exacerbation least one month study . Exclusion criterion : Uncooperative patient judge physician . Patients condition , accord participate physician 's opinion , might decrease chance obtain satisfactory data achieve objective observation study . Patients condition exclude per Country specific package insert . Patients currently enrol another clinical trial require change medication respiratory problem .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>